Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Bifu Jinbei Pharmaceutical is a comprehensive pharmaceutical manufacturer based in Harbin, China, specializing in the production of chemical drugs and traditional Chinese medicines. As a subsidiary of the Bifu Group, the company leverages its large-scale, GMP-certified facilities to produce a wide array of therapeutic products under the well-recognized "Jinbei" brand. Its portfolio primarily focuses on high-demand therapeutic areas including respiratory health, metabolic disorders, and anti-infectives. The company is a significant player in the Chinese domestic market, providing both over-the-counter (OTC) and prescription medications in various dosage forms such as tablets, capsules, and granules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Bifu Jinbei Pharmaceutical.